Celltrion Healthcare starts to expand business into the Latin America

Celltrion Healthcare has started the engine to enlarge its market share in the Latin American market by signing a distribution and sales agreement of ‘Truxima(generic name: rituximab),’ a biosimilar for the treatment of hematologic malignancy, in Colombia with a global pharmaceutical company Mundi Pharmaa.

Colombia, one of pharmerging – meaning that a new emerging pharmaceutical market – count...